Full Text
Amnog Benefit Assessment- Time Delay of Market Access for Pharmaceuticals in Germany?

Abstract

Authors

A.S. Neubauer P. Voss A. Gmeiner G. Neubauer

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×